The 4 Areas BOTOX® Cosmetic Is FDA-Approved to Treat
What this article covers (and why it matters)
- Scope: We focus on FDA-approved aesthetic indications for BOTOX® Cosmetic and how that compares at a high level to other neuromodulators. Indications can differ by brand.
- Why you should care: Safety, candidacy, and expectations hinge on whether a use is on-label, your anatomy and goals, and your provider’s skill—not marketing claims.
- Source note: Allergan Aesthetics (an AbbVie company) recently announced “The One & Only” campaign for BOTOX® Cosmetic spotlighting its four FDA-approved aesthetic areas. See the source for context: AbbVie News Center.
Table of Contents
The 4 FDA‑approved aesthetic areas for BOTOX® Cosmetic
BOTOX® Cosmetic (onabotulinumtoxinA) is FDA‑approved in adults for temporary improvement in the appearance of four aesthetic areas. Treatment is individualized by licensed providers; units are product-specific and not interchangeable between brands.
1. Frown lines (glabellar lines)
- What they are: The vertical “11s” that form between the eyebrows from repeated brow furrowing.
- Treatment goal: Soften the appearance of moderate to severe lines while preserving a natural look.
2. Crow’s feet (lateral canthal lines)
- What they are: Fine lines radiating from the outer corners of the eyes, often more visible when smiling.
- Treatment goal: Smooth the eye area for a refreshed, less-tired appearance.
3. Forehead lines (horizontal frontalis lines)
- What they are: Horizontal lines across the forehead caused by repeated brow elevation.
- Treatment goal: Reduce moderate to severe lines while maintaining natural brow movement.
4. Vertical neck bands (platysma bands)
- What they are: Prominent vertical bands that can appear between the jaw and neck due to platysma muscle activity.
- Treatment goal: Soften the appearance of these bands for a sleeker neck–jawline transition.
Important reminders
- Results are temporary; many patients plan touch-ups every 3–4 months, though timing varies.
- Dose, injection pattern, and technique are tailored to your facial anatomy and goals.
- Only a licensed, trained professional should inject botulinum toxin products.
How other neurotoxins fit: quick comparisons
Xeomin Cosmetic® (incobotulinumtoxinA)
- Known for a “naked” formulation (no accessory proteins), which some clinicians discuss in the context of immunogenicity considerations.
- Shares upper-face aesthetic indications in the U.S. market; available to treat forehead lines, frown lines, and crow’s feet.
- Onset and duration are broadly similar for many patients; experiences vary, and units are not interchangeable.
Dysport® (abobotulinumtoxinA)
- Clinically, some providers observe a faster onset and different diffusion characteristics compared to onabotulinumtoxinA; experiences vary by patient and technique.
- Unit-to-unit conversion with other toxins is not 1:1; dosing paradigms are product-specific.
- Clinically proven for a natural-looking treatment for frown lines between the brows. Results may last up to 5 months per treatment.
Bottom line on comparisons
- The right choice depends on your goals, anatomy, prior response, and your injector’s experience with each product.
- Marketing campaigns raise awareness; they don’t replace label specifics or clinical judgment.
Critical safety warning: counterfeit botulinum toxins in the U.S.
In recent months, regulators and professional societies have warned about counterfeit or unapproved botulinum toxin products entering U.S. medical settings. This poses serious risks:
Patient safety risks
- Unknown composition, potency, sterility, and contamination risk.
- Potential for adverse events that do not align with expectations for approved products.
- Unreliable dosing could lead to poor outcomes, asymmetry, eyelid/brow ptosis, or systemic effects.
Provider and practice risks
- Using counterfeit/unapproved products can void malpractice coverage and expose providers and clinics to regulatory and legal actions.
- Supply chains matter: Purchasing outside authorized distributors or using deeply discounted, non-traceable sources is a red flag.
How patients can protect themselves
Ask to see the product box and vial before injection. Check:
- Brand name and exact product (e.g., BOTOX® Cosmetic, Xeomin®, Dysport®).
- U.S. FDA labeling, lot number, and expiration date.
- Intact packaging and tamper-evident seals.
Verify your injector is appropriately licensed, certified and trained, and operating in a legitimate medical setting. Be wary of “party” settings and unusually low prices.
How providers can protect patients and their practice
- Source only from authorized U.S. distributors with full product traceability.
- Keep meticulous lot and vial records in patient charts.
- Educate patients on why reputable sourcing and proper medical oversight are non-negotiable.
If you suspect a counterfeit or experience an adverse event, report it promptly through appropriate channels (e.g., FDA’s MedWatch) and follow local regulations.
Practical considerations when choosing a product
- Individualization over brand hype: Your musculature, skin quality, and aesthetic priorities guide product and dosing decisions.
- Experience matters: An injector experienced with a given product often achieves more consistent, natural results.
- Expect variation: Onset, duration, and “feel” differ by person and by area treated.
- Think yearly plan: Consider total cost, maintenance cadence, and combination treatments (e.g., skincare, lasers, fillers) when relevant.
Safety snapshot (class considerations)
All botulinum toxin products carry important safety risks, including a boxed warning regarding the potential spread of toxin effect, with rare but serious issues such as problems swallowing, speaking, or breathing. Not everyone is a candidate. Disclose medical history, neuromuscular conditions, pregnancy/breastfeeding status, and all medications/supplements to your provider. Dosing units differ across brands and are not interchangeable.
For full details, review each product’s Prescribing Information and Medication Guide on official brand sites or the FDA database.
Bottom line
BOTOX® Cosmetic is FDA-approved to treat four aesthetic areas: glabellar lines, crow’s feet, forehead lines, and vertical platysma bands in adults. Competitors like Xeomin® and Dysport® may share some upper-face indications but differ in formulation, dosing, and labeled uses. Choose based on indications, anatomy, and injector expertise—and insist on authentic, FDA-approved product sourced through authorized channels.
Ready to build confidence injecting neurotoxins? Explore hands-on, evidence-based training with IAPAM to strengthen safety, anatomy, and technique—so treatments stay patient-centered and compliant.
Aesthetic Medicine Certification & Excellence
Earn your certification and designation as trusted Certified Aesthetic Provider™ (CAP) and show your patients your commitment to the highest standards in training and care.
From Botox® and fillers to PRP, PDO threads, chemical peels and more, this is your one stop shop for CME-accredited training from an internationally-recognized association with 20 years of aesthetic medicine excellence.
